Hirata, S.; Kono, Y.; Tanaka, E.; Sue, M.; Takeuchi, Y.; Yoshikawa, T.; Maki, Y.; Kamio, T.; Kametaka, D.; Matsueda, K.;
et al. Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint Inhibitors. Cancers 2025, 17, 2634.
https://doi.org/10.3390/cancers17162634
AMA Style
Hirata S, Kono Y, Tanaka E, Sue M, Takeuchi Y, Yoshikawa T, Maki Y, Kamio T, Kametaka D, Matsueda K,
et al. Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint Inhibitors. Cancers. 2025; 17(16):2634.
https://doi.org/10.3390/cancers17162634
Chicago/Turabian Style
Hirata, Shoichiro, Yoshiyasu Kono, Emi Tanaka, Masahiko Sue, Yasuto Takeuchi, Tomoki Yoshikawa, Yoshie Maki, Tomohiro Kamio, Daisuke Kametaka, Katsunori Matsueda,
and et al. 2025. "Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint Inhibitors" Cancers 17, no. 16: 2634.
https://doi.org/10.3390/cancers17162634
APA Style
Hirata, S., Kono, Y., Tanaka, E., Sue, M., Takeuchi, Y., Yoshikawa, T., Maki, Y., Kamio, T., Kametaka, D., Matsueda, K., Sakaguchi, C., Hamada, K., Iwamuro, M., Kawano, S., Kawahara, Y., & Otsuka, M.
(2025). Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint Inhibitors. Cancers, 17(16), 2634.
https://doi.org/10.3390/cancers17162634
